Details for New Drug Application (NDA): 065408
✉ Email this page to a colleague
NDA 065408 describes EPIRUBICIN HYDROCHLORIDE, which is a drug marketed by Actavis Totowa, Cipla Ltd, Ebewe Pharma, Epic Pharma Llc, Fresenius Kabi Usa, Hikma, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Norvium Bioscience, and Zennova, and is included in fourteen NDAs. It is available from one supplier. Additional details are available on the EPIRUBICIN HYDROCHLORIDE profile page.
The generic ingredient in EPIRUBICIN HYDROCHLORIDE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
The generic ingredient in EPIRUBICIN HYDROCHLORIDE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
Summary for 065408
| Tradename: | EPIRUBICIN HYDROCHLORIDE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | epirubicin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065408
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/5ML (2MG/ML) | ||||
| Approval Date: | Oct 15, 2007 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/25ML (2MG/ML) | ||||
| Approval Date: | Oct 15, 2007 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/75ML (2MG/ML) | ||||
| Approval Date: | Oct 15, 2007 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
